Sale of 500 shares at $12.70 per share.
Reporting Person Shook David · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 10, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001959742-26-000003 · filed 2026-09-10 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Lyell Immunopharma, Inc. (LYEL)." Disclosed 2026-09-10. https://desqlong.com/cards/0001959742-26-000003-1 (retrieved 2026-09-26).